Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.02
+0.04 (0.14%)
At close: Sep 18, 2026, 4:00 PM EDT
27.92
-0.10 (-0.36%)
After-hours: Sep 18, 2026, 7:34 PM EDT
Mineralys Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $52 | Buy | Reiterates | $52 | +85.58% | Aug 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $49 | Buy | Reiterates | $49 | +74.88% | Aug 12, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $42 → $40 | Buy | Maintains | $42 → $40 | +42.76% | Aug 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +96.29% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $54 | Buy | Maintains | $54 | +92.72% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $56 | Buy | Reiterates | $56 | +99.86% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $52 | Buy | Maintains | $52 | +85.58% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |